Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 300
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
HAVN Life Sciences Inc., a biotechnology company, engages in research and development of products for addressing mental health disorders. The company is developing formulations to support clinical trials addressing PTSD recovery and other trauma related disorders. It also focuses on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatment t...
Show more
HAVN Life Sciences Inc., a biotechnology company, engages in research and development of products for addressing mental health disorders. The company is developing formulations to support clinical trials addressing PTSD recovery and other trauma related disorders. It also focuses on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatment to support brain health and enhance the capabilities of the mind. The company was incorporated in 2020 and is based in Port Moody, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 604 370 9520
- Website
- https://www.havnlife.com
- Address
- 130 Brew Street, Suite 605, Port Moody, Canada
Latest news
No headlines yet.
